ADVERTISEMENT

Concerns That Low LDL-C Alters Cognitive Function Challenged in Novel Analysis

Medical News   |   08 August 2022
ADVERTISEMENT

FROM THE JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

PCSK9 inhibitors, which are among the most effective therapies for reducing LDL cholesterol (LDL-C), are associated with a neutral effect on cognitive function, according to a genetics-based Mendelian randomization study intended to sort out through the complexity of confounders.

The same...

          

Topic Challenges

left
right